
|Videos|September 14, 2015
Shared Decision Making in Colorectal Cancer
Advertisement
Episodes in this series

Shared decision making between physician and patient is very common, says John L. Marshall, chief, Division of Hematology/Oncology, Georgetown University Hospital, associate director, Clinical Research, Lombardi Comprehensive Cancer Center.
Most patients want to choose a therapy based solely on efficacy, but, as a physician, I need to be sure they’re aware of toxicities, cost, and more.
“[A]ll these things do come into one big decision plan before I make the final decision about which treatment to choose,” Cathy Eng, professor and director, Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, says.
Advertisement
Related to this article

Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
Advertisement
Advertisement
Trending on CURE
1
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
2
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
3
Neuro-Oncologist Answers Common Questions About Brain Cancer Diagnosis and Treatment
4
3 ESMO 2026 Results in Endometrial and Breast Cancer to Know
5







